MetaCap

Citius Oncology (CTOR) vs XBiotech (XBIT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

XBiotech (XBIT) has outperformed Citius Oncology (CTOR) over the past year, losing 24.1% versus a loss of 55.4%. Citius Oncology is the larger company by market cap ($53.2 million vs $52.7 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CTOR-55.44%XBIT-24.12%
+50%-6%-61%
Nov 21, 20251 yearNov 20, 2026
CTOR-95.01%XBIT-45.77%
+321%+103%-115%
Dec 5, 20225 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CTOR versus XBIT key metrics
MetricCTORXBIT
Share price$0.5035$1.73
Market cap$53.25M$52.74M
1-day change-10.95%+2.98%
YTD return-49.65%-27.62%
1-year return-55.44%-24.12%
5-year return—-86.48%
Forward P/E—13.31
EPS (TTM)$-0.48$-1.43
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-24.76M$-45.54M
52-week high$1.83$2.73
52-week low$0.491$1.61
Distance from 52-week high-72.49%-36.63%
Analyst consensusnone—
Avg. price target upside+694.44%—
Average volume114.02K64.77K
Shares outstanding105.76M30.49M
Employees—87
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • XBIT has outperformed CTOR by 31.3 percentage points over the past year.

About Citius Oncology

CTOR stock →

Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.

Health Care · Biotechnology: Pharmaceutical Preparations

About XBiotech

XBIT stock →

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees

CTOR vs XBIT FAQ

Which is bigger, Citius Oncology or XBiotech?

Citius Oncology (CTOR) is larger, with a market capitalization of $53.25M compared with $52.74M for XBiotech (XBIT).

Which stock has performed better over the past year, CTOR or XBIT?

XBIT returned -24.12% over the past 12 months, compared with -55.44% for CTOR (price return, excluding dividends). Past performance does not predict future results.

Are Citius Oncology and XBiotech in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons